GRI Bio Inc. Common Stock (GRI)
Stock · NASDAQ · Health Care
$1.92as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Resistance level
$2.31
Industry
Biotechnology: Pharmaceutical Preparations
About GRI
GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natural Killer T cells, which is in phase IIa clinical trial for the treatment of severe fibrotic lung diseases, such as idi…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 3
- Website
- www.gribio.com
Fundamentals
- 1-day range
- $1.82$2.1
- Market cap
- $2.55M
- P/E (trailing)
- —
- P/E (forward)
- -1.02
- EPS (trailing)
- $-2.83
- Dividend yield
- —
- Beta
- -0.66
- Avg. volume
- 186.0K
52-week range
$1.36$80.36
Forecasts
2 analyst ratings
Buy 100%
Hold 0%
Sell 0%
1-year price forecast
High
$27
+1306.3%
Median
$18.5
+863.5%
Low
$10
+420.8%
GRI Bio Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- GRIGRI Bio Inc. Common Stock$1.92▼ 7.25%Market cap $2.55MP/E —$1.36$80.36
- ARTLArtelo Biosciences Inc. Common Stock$0.6619▲ 0.14%Market cap $2.59MP/E —$0.52$28.14
- SBFMSunshine Biopharma Inc. Common Stock$1.16▼ 8.66%Market cap $2.48MP/E —$1.01$24.3
- OGENOragenics Inc. Common Stock$0.5296▼ 0.08%Market cap $2.39MP/E —$0.4801$1.45
- SXTCChina SXT Pharmaceuticals Inc. Class A Ordinary Shares$3▼ 13.29%Market cap $2.94MP/E —$3.1$83,758
- SXTP60 Degrees Pharmaceuticals Inc. Common Stock$1.03▼ 2.83%Market cap $3.08MP/E —$1.01$8.62
- MTNBMatinas Biopharma Holdings Inc. Common Stock$0.1966▼ 1.70%Market cap $1.93MP/E —$0.178$2.14
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| GRI GRI Bio Inc. Common Stock | $2.55M | — | $1.92 | ▼ 7.25% | $1.36$80.36 |
| ARTL Artelo Biosciences Inc. Common Stock | $2.59M | — | $0.6619 | ▲ 0.14% | $0.52$28.14 |
| SBFM Sunshine Biopharma Inc. Common Stock | $2.48M | — | $1.16 | ▼ 8.66% | $1.01$24.3 |
| OGEN Oragenics Inc. Common Stock | $2.39M | — | $0.5296 | ▼ 0.08% | $0.4801$1.45 |
| SXTC China SXT Pharmaceuticals Inc. Class A Ordinary Shares | $2.94M | — | $3 | ▼ 13.29% | $3.1$83,758 |
| SXTP 60 Degrees Pharmaceuticals Inc. Common Stock | $3.08M | — | $1.03 | ▼ 2.83% | $1.01$8.62 |
| MTNB Matinas Biopharma Holdings Inc. Common Stock | $1.93M | — | $0.1966 | ▼ 1.70% | $0.178$2.14 |
P/E shows — for peers not currently carrying a live signal of their own.
Institutional Ownership
March 31, 2026
- Total shares held
- 28.2K
- Total value held
- $64.7K
- Institutional holders
- 6
Top holders this quarter
- Unknown18.4K
- Unknown8.7K
- Unknown1.1K
- Unknown7
- Unknown4
- Unknown2
See the full, filterable feed with live charts on the MarketWall dashboard.